Vantage logo

Insulet comes out fighting

Pivotal data on its closed-loop insulin delivery system look good, but Medtronic remains a threat.

Vantage logo

Covid-19 divides the biggest medtechs

Success or failure on the stock markets this year depended almost entirely on whether a company’s devices could be used to treat coronavirus patients.

Vantage logo

Collaborative diabetes tech on the Horizon

For diabetes devices interoperability is key, and partnerships between Insulet, Dexcom and Abbott show that rival groups see the benefits of working together.

Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.